CS Medica AS (XSAT:CSMED) ROCE % : -83.58% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is CS Medica AS ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. CS Medica AS's annualized ROCE % for the quarter that ended in Jun. 2024 was -83.58%.

CS Medica AS ROCE % Historical Data

The historical data trend for CS Medica AS's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CS Medica AS ROCE % Chart

CS Medica AS Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

ROCE %

6.89

1.85

-1.17

-51.63

-80.11

CS Medica AS Quarterly Data
	Sep19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
ROCE %	Get a 7-Day Free Trial													-88.37	-95.22	-86.20	-45.41	-83.58

CS Medica AS ROCE % Calculation

CS Medica AS's annualized ROCE % for the fiscal year that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Sep. 2023 )		(A: Sep. 2022 )		(A: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Sep. 2023 )		(A: Sep. 2022 )		(A: Sep. 2023 )
	=	-17.899	/	( ( (27.906 - 2.219)	+	(25.855 - 6.854) )	/ 2 )
	=	-17.899	/	( (25.687	+	19.001)	/ 2 )
	=	-17.899	/	22.344
	=	-80.11 %

CS Medica AS's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Mar. 2024 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Mar. 2024 )		(Q: Jun. 2024 )
	=	-14.452	/	( ( (33.728 - 14.893)	+	(34.167 - 18.42) )	/ 2 )
	=	-14.452	/	( ( 18.835	+	15.747 )	/ 2 )
	=	-14.452	/	17.291
	=	-83.58 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

CS Medica AS (XSAT:CSMED) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

CS Medica AS ROCE % Related Terms

Thank you for viewing the detailed overview of CS Medica AS's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

CS Medica AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CS Medica AS (XSAT:CSMED) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

8G8:Germany

Address

Fruebjergvej 3, Copenhagen, DNK, 2100

Website

https://www.cs-medica.com

CS Medica AS is engaged in developing, manufacturing, and commercializing over-the-counter medical device products containing cannabinoids currently focusing on cannabidiol for the treatment of psoriasis and arthritis.

CS Medica AS Headlines

No Headlines